https://www.pharmacytimes.com/view/empagliflozin-reduces-myocardial-glucose-metabolic-rate-for-type-2-diabetes-patients-without-coronary-artery-disease
0
0
8/19/22 at 3:17pm
Organization
Pharmacytimes.com
Author
Lindsey Mulrooney
Treatment with empagliflozin also found to improve cardiac geometry, myocardial mechano-energetic efficiency, and cardiac function.
Create an account
or login to join the discussion